rhPDGF-BB Promotes Proliferation and Osteogenic Differentiation of Bone Marrow Stromal Cells from Streptozotocin-Induced Diabetic Rats through ERK Pathway

Figure 1

Effects of rhPDGF-BB on proliferation of diabetic BMSCs. (a) MTT assay results of diabetic BMSCs treated with or without rhPDGF-BB (5–100 ng/mL) for 7 days, *𝑃<0.05, versus control, and ^#𝑃<0.05, versus 50 ng/mL. (b) MTT assay results of diabetic BMSCs treated with or without rhPDGF-BB (10 ng/mL or 50 ng/mL) for 2, 4 and 7 days, *𝑃<0.05, versus control, and ^#𝑃<0.05, versus 10 ng/mL.

(a)

(b)